Issue 7/2019
Content (11 Articles)
Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation
Lee S. Nguyen, Mathieu Vautier, Yves Allenbach, Noel Zahr, Olivier Benveniste, Christian Funck-Brentano, Joe-Elie Salem
Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management
Kim M. Blakely, Aaron M. Drucker, Cheryl F. Rosen
Pharmacovigilance Systems in Arab Countries: Overview of 22 Arab Countries
Thamir M. Alshammari, Neslihan Mendi, Khalidah A. Alenzi, Yazed Alsowaida
Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
Xiao Ding, Qianqian Li, Pan Li, Ting Zhang, Bota Cui, Guozhong Ji, Xiang Lu, Faming Zhang
Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study
Sieta T. de Vries, Judy Harrison, Patrick Revelle, Alicia Ptaszynska-Neophytou, Anna Radecka, Gowthamei Ragunathan, Phil Tregunno, Petra Denig, Peter G. M. Mol
Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study
Lotte A. Minnema, Thijs J. Giezen, Patrick C. Souverein, Toine C. G. Egberts, Hubert G. M. Leufkens, Helga Gardarsdottir
Use of FDA’s Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine Exposure
Efe Eworuke, Emily C. Welch, Anne Tobenkin, Judith C. Maro
Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative Chlorobutanol
R. David Woosley, Klaus Romero, Craig W. Heise, Tyler Gallo, Jared Tate, Raymond L. Woosley
A Profile of Adverse Drug Reactions of Atazanavir- and Lopinavir-Based Antiretroviral Regimens in Namibia
Babafunso Aderemi Adenuga, Timothy William Rennie
Correction to: Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists
Rasmus M. Christensen, Christian R. Juhl, Signe S. Torekov